Aspiriant LLC’s WisdomTree Europe Hedged Equity Fund HEDJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-10,902
Closed -$340K – 209
2017
Q2
$340K Buy
+10,902
New +$353K 0.03% 164
2016
Q4
– Sell
-73,730
Closed -$1.98M – 186
2016
Q3
$1.98M Sell
73,730
-384,314
-84% -$10.2M 0.2% 71
2016
Q2
$12.7M Buy
+458,044
New +$11.9M 1.2% 14
2014
Q4
– Sell
-8,440
Closed -$244K – 94
2014
Q3
$244K Sell
8,440
-13,956
-62% -$402K 0.03% 72
2014
Q2
$654K Sell
22,396
-8,580
-28% -$250K 0.09% 56
2014
Q1
$876K Buy
+30,976
New +$856K 0.13% 55

Other funds holding HEDJ

Aspiriant LLC's HEDJ Position: Q3 2017 in Review

Aspiriant LLC sold out of WisdomTree Europe Hedged Equity Fund (HEDJ) in Q3 2017, closing a stake of 10,902 shares — an estimated $340K sold.

Aspiriant LLC first reported a position in HEDJ in Q1 2014 and held it in 6 quarters. The position peaked at $12.7M in Q2 2016. 305 funds tracked by Wall St. Rank hold HEDJ as of Q3 2017.

  • Aspiriant LLC reported no remaining WisdomTree Europe Hedged Equity Fund position as of Q3 2017 after selling out during the quarter.
  • Aspiriant LLC sold 10,902 WisdomTree Europe Hedged Equity Fund shares in Q3 2017, an estimated $340K.
  • Aspiriant LLC first reported a position in WisdomTree Europe Hedged Equity Fund in Q1 2014 and held it in 6 quarters.
  • Aspiriant LLC's WisdomTree Europe Hedged Equity Fund position peaked at $12.7M in Q2 2016.
  • 305 funds tracked by Wall St. Rank held WisdomTree Europe Hedged Equity Fund as of Q3 2017.

Based on Aspiriant LLC's 13F filing for Q3 2017, filed 13 Nov 2017.